| Value | ₹0.25 Cr |
|---|---|
| Execution period | 4 years |
BSE filing, NSE: CLEAN. Summary written from the filing by ALFA Finder's alert engine.
Clean Science & Technology Ltd: key numbers
- Share price
- ₹740.20
- Market cap
- ₹7,867 Cr
- Revenue (annual)
- ₹956.5 Cr
- Net profit (annual)
- ₹229.7 Cr
- P/E (TTM)
- 33.8×Sector 34.1×
- Promoter holding
- 51.29%+0.00% QoQ
- FII holding
- 13.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clean Science & Technology Ltd
All →Clean Science & Technology Business Update
Clean Science's subsidiary Clean Fino-Chem completed product trials for advanced HALS grades developed with Geneus Chem AG. Commercial launch of the new range is expected in H2 FY2026-27.
Clean Science & Technology Other Announcement
Clean Science and Technology Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Clean Science & Technology Board Meeting Date
Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.
Clean Science & Technology Legal & Regulatory
Clean Science concluded GST proceedings, resulting in a ₹2.0 crore net financial impact. A further ₹9.9 crore liability is recoverable as Input Tax Credit.
- Value
- ₹11.90 Cr
Clean Science & Technology Credit Rating
CRISIL reaffirmed Clean Science's long-term rating at AA-/Stable and short-term at A1+. The rating action signals continued stable credit quality with no change.
Clean Science & Technology Legal & Regulatory
GST authorities initiated search and seizure proceedings at the company's premises. The company reports no material impact on financials or business operations at this stage.
Other employee stock options announcements
All →Cholamandalam Investment & Finance Company Employee Stock Options
Cholamandalam Investment and Finance allotted 1,20,202 equity shares to employees upon the exercise of stock options. The company will now seek listing for these shares.
Mahindra & Mahindra Employee Stock Options
Mahindra & Mahindra transferred equity shares from its ESOP Trust to employees upon exercise of stock options. This is a routine employee benefit disclosure.
JSW Energy Employee Stock Options
JSW Energy's employee welfare trust transferred 10,044 shares to employees after ESOP option exercises. The off-market transfer was valued at about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Indegene Employee Stock Options
Indegene Limited allotted 52,194 equity shares under its ESOP schemes, raising paid-up capital to Rs.48.21 Crore. No cash fund raise is involved, so no event value applies.
Raymond Employee Stock Options
Raymond allotted 1,56,784 equity shares to its ESOP Trust under the Raymond Employees Stock Option Plan 2023. Paid-up capital rose to Rs. 66,73,05,150.
Alivus Life Sciences Employee Stock Options
Alivus Life Sciences allotted 1,95,833 equity shares to an employee who exercised ESOP options under its 2021 scheme. Paid-up capital rises to Rs. 24.59 Crore.